Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Amy brings over three decades of experience in for-profit and nonprofit business management and ownership. In December 2017, she joined The Global Resource for Advancing Cancer Education as its Executive Director. She directs its growth in strategy, revenue, outreach, partnership, and programs.
GRACE Fellows Ambassador Program Winners
dbrock
GRACE Fellows Ambassador Program for the 2019-2020 Program Year
Image
GRACE is pleased to announce the acceptance of two rising stars in to the inaugural GRACE Fellows Ambassador Program for the 2019-2020 Program Year!
Both candidates have shown a genuine passion for patient education and innovation in connecting with the patient community. The program will encompass the participants creating content which will be featured on the GRACE website, working alongside GRACE faculty, Board and staff, and learning the most current and effective communication skills needed to succeed in their field. The Fellows Ambassador Program starts July 1, 2019 and ends on June 30, 2020.
We are excited to work with both of them over the next year to continue to educate cancer patients on the most current and emerging treatment options. Watch for new videos, articles, and podcasts featuring the passions that these two amazing fellows have to share with the community!
2019 GRACE Fellows Ambassador Program Winners
Arjun is a medical oncology fellow at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore. He has served as the Chief Resident for Quality, Patient Safety, and High-Value Care in the Department of Internal Medicine at UT Southwestern Medical Center, and the inaugural Learning Network Fellow for Costs of Care. His interests are in improving oncology care processes and high-value care.
Narjust (NJ) is a hematologist and oncologist Fellow at Mayo Clinic, in Rochester, Minnesota. In addition to her dedication to her patients as a provider, Dr. Duma is committed to her research and advocacy in diversity and inclusion. She was recognized as the 2018 resident of the year by the National Hispanic Medical Association.
Dr. Duma was selected by her peers to be a diversity and inclusion champion. She works with medical students and residents to help them feel more comfortable with Rochester, Minnesota and Mayo Clinic. Her research also focuses on underrepresented patient populations in clinical trials and how it affects the treatment of cancer patients.
Dr. Duma credits her background and upbringing with helping prepare her for her career.
Congratulations Drs. Gupta and Duma!
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Article
Get Ready to Explore the Refreshed
Global Resource for Advancing Cancer Education Website!
Look at our new look! View a quick video walkthrough below.
GRACE has a fresh new look, and we’re excited to share it with you! What hasn’t changed is everything you count on—reliable, free resources including videos, articles, podcasts, live interactive webinars, and our supportive online community.
Image
Article
GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26 Program Year!
Applications for this program are open in March every year. To be notified when applications for this program open, please email Amy Bickleman, Executive Director, at abickleman@cancergrace.org to be added to the notification list.
Online Community
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Recent Comments
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: